A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
The primary objective of this study is to estimate the proportion of people with low/intermediate/high risk of advanced fibrosis in at risk Chinese population based on the European Association for the Study of the Liver (EASL) 2024 care pathway
Inclusion Criteria:
For All and Study population:
For EASL at risk population
For EASL not at-risk population
1. Must be part of study population.
For EASL-SAFE
For AGA at risk population
For CSH MAFLD population
Exclusion Criteria:
For EASL not at-risk population 1. People with T2D or [obesity+above or equal to 1 cardiometabolic risk factor(s)] or elevated liver enzymes
For EASL-SAFE/NFS
1. Missing value on globulin